Veeva’s Falcon AI Platform Promises Biopharma Revolution—Investors Weigh Risks, Gains
Veeva’s new Falcon platform promises AI‑powered biopharma automation, but investor caution and price‑target cuts show the market still doubts its commercial rollout.
4 minutes to read